{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-063326","form_type":"8-K","ticker":"PROK","cik":"0001850270","company_name":"PROKIDNEY CORP.","filed_at":"2023-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.046270+00:00","generated_at":"2026-06-08T04:01:47.073665+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"ProKidney Q3 net loss widens to $42M; cash runway into Q4 2025","bullets":["Net loss $42.0M for Q3 2023 vs $33.9M for Q3 2022, driven by higher R&D costs.","Cash, equivalents and marketable securities $396.3M at Sep 30, down from $490.3M at Dec 31, 2022.","R&D expenses $32.2M in Q3 2023 vs $21.1M in Q3 2022, up 53% on clinical trial and staffing costs.","G&A expenses flat at $14.4M; equity-based compensation offset prior-year business combination costs.","Cash expected to fund operations into Q4 2025; 235.4M ordinary shares outstanding at Sep 30."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-063326","json":"https://secwatch.observer/filing/0000950170-23-063326.json","markdown":"https://secwatch.observer/filing/0000950170-23-063326.md","text":"https://secwatch.observer/filing/0000950170-23-063326.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1850270/000095017023063326/0000950170-23-063326-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1850270/000095017023063326/prok-20231114.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T04:01:47.073665+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"cc39b052c66ae7e22854f4d40755e406a6ae5051","claim":"PROKIDNEY CORP. reported financial results for the third quarter ended September 30, 2023.","evidence_excerpt":"On November 14, 2023, ProKidney Corp. issued a press release to announce its financial results for the quarter ended September 30, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017023063326/0000950170-23-063326-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the third quarter ended September 30, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}